Periodic Reporting for period 1 - NANO-GROWTH (An innovative, non-invasive and de-risked system to enable the transdermal delivery of fragile therapeutic compounds for a better management of painful diseases)

The global prevalence of pain in adults is around 20% with chronic pain affecting up to 8% of the global population. There is an unmet need for safe, long-term and cost-efficient pain management therapies. In particular diabetes neuropathy pain affects 10% of diabetic patients...